Immunohistochemistry as an important tool in biomarkers detection and clinical practice

Biomarker Insights

Volumn 2010, Issue 5, 2010, Pages 9-20

  de Matos, Leandro Luongo ^a   Trufelli, Damila Cristina ^a   de Matos, Maria Graciela Luongo ^a   Pinhal, Maria Aparecida da Silva ^a  

^a FACULDADE DE MEDICINA DO ABC   (Brazil)

Author keywords

Immunohistochemistry; Pathology; Review

Indexed keywords

BIOLOGICAL MARKER;

ANTIGEN RETRIEVAL; CELL CULTURE; CLINICAL ASSESSMENT TOOL; CLINICAL PRACTICE; CLINICAL RESEARCH; COMPUTER ANALYSIS; DIAGNOSTIC PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MEDICAL INFORMATION; PATHOLOGICAL ANATOMY; PROGNOSIS; QUANTITATIVE ANALYSIS; REVIEW; SENSITIVITY AND SPECIFICITY; TISSUE CULTURE TECHNIQUE;

EID: 77951281239     PISSN: None     EISSN: 11772719     Source Type: Journal    
DOI: 10.4137/bmi.s2185     Document Type: Review

References (127)

1. Brandtzaeg P. The increasing power of immunohistochemistry and immunocytochemistry. J Immunol Methods. 1998;216:49-67.
2. Alves VAF, Bacchi CE, Vassallo J. Manual de Imuno-histoquímica. São Paulo: Sociedade Brasileira de Patologia. 1999.
3. Haines DM, West KH. Immunohistochemistry: forging the links between immunology and pathology. Vet Immunol Immunopathol. 2005;108:151-6.
4. Marrack J. Nature of antibodies. Nature. 1934;133:292-3.
5. Coons AH, Creech HJ, Jones RN. Immunological properties of an antibody containing a fluorescence group. Proc Soc Exp Biol Med. 1941;47:200-2.
6. Avrameas S, Uriel J. Method of antigen and antibody labelling with enzymes and its immunodiffusion application. C R Acad Sci Hebd Seances Acad Sci D. 1966;262:2543-5.
7. Nakane PK, Pierce Jr GB. Enzyme-labeled antibodies: preparation and application for the localization of antigens. J Histochem Cytochem. 1966;14:929-31.
8. Nakane PK. Simultaneous localization of multiple tissue antigens using the peroxidase-labeled antibody method: a study on pituitary glands of the rat. J Histochem Cytochem. 1968;16:557-60.
9. Sternberger LA, Hardy Jr PH, Cuculis JJ, et al. The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish per-oxidase) and its use in identification of spirochetes. J Histochem Cytochem. 1970;18:315-33.
10. Mason DY, Sammons R. Alkaline phosphatase and peroxidase for double immunoenzymatic labelling of cellular constituents. J Clin Pathol. 1978;31: 454-60.
11. Mason DY, Sammons R. Rapid preparation of peroxidase: anti-peroxidase complexes for immunocytochemical use. J Immunol Methods. 1978;20: 317-24.
12. Cordell JL, Falini B, Erber WN, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem. 1984;32:219-29.
13. Singer SJ. Preparation of an electron-dense antibody conjugate. Nature. 1959; 183:1523-4.
14. Sternberger LA. Electron microscopic immunocytochemistry: a review. J Histochem Cytochem. 1967;15:139-59.
15. Faulk WP, Taylor GM. An immunocolloid method for the electron microscope. Immunochemistry. 1971;8:1081-3.
16. Roth J. Bullock, G R and Petrusz, P. ed. Techniques in Immunocytochemistry. Academic Press. 1982: p. 107-20.
17. Huang SN, Minassian H, More JD. Application of immunofluorescent staining on paraffin sections improved by trypsin digestion. Lab Invest. 1976;35:383-90.
18. Hsu SM, Raine L. Protein A, avidin, and biotin in immunohistochemistry. J Histochem Cytochem. 1981;29:1349-53.
19. Hsu SM, Raine L, Fanger H. A comparative study of the peroxidaseantiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol. 1981a;75:734-8.
20. Hsu SM, Raine L, Fanger H. The use of antiavidin antibody and avidinbiotin-peroxidase complex in immunoperoxidase technics. Am J Clin Pathol. 1981b;75:816-21.
21. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981c;29:577-80.
22. Leong AS, Wright J. The contribution of immunohistochemical staining in tumour diagnosis. Histopathology. 1987;11:1295-305.
23. Taylor CR, Cote RJ. Immunomicroscopy: a diagnostic tool for surgical pathologist. In: ed. Major Problems in Pathology. Nova Iorque: WB Sauders. 1994. p.
24. Rosai J. Special techniques in surgical pathology. In: ed. Ackerman's Surgical Pathology. Nova Iorque: Mosby-Year Book. 1996. p. 29-62.
25. Swanson PE. HIERanarchy: the state of the art in immunohistochemistry. Am J Clin Pathol. 1997;107:139-40.
26. Bodey B. The significance of immunohistochemistry in the diagnosis and therapy of neoplasms. Expert Opin Biol Ther. 2002;2:371-93.
27. Werner B, Campos AC, Nadji M, et al. Uso prático da imuno-histoquímica em patologia cirúrgica. J Bras Patol Med Lab. 2005;41:353-64.
28. Nadji M. Immunoperoxidase techniques. I. Facts and artifacts. Am J Dermatopathol. 1986;8:32-6.
29. Rickert RR, Maliniak RM. Intralaboratory quality assurance of immunohistochemical procedures. Recommended practices for daily application. Arch Pathol Lab Med. 1989;113:673-9.
30. Schmitt FC. Utilidade dos métodos imuno-histoquímicos para o diagnóstico anatomopatológico. Rev Hosp Clin Fac Med Sao Paulo. 1991;46:26-30.
31. Torres LFB, Noronha L, Telles J. A importância da imuno-histoquímica no diagnóstico anatomopatológico em hospital geral: análise de 885 casos. J Bras Patol Med Lab. 1995;31.
32. Torres LFB. A contribuição da imuno-histoquímica em patologia cirúrgica: experiência de 10 anos. Rev Med Paraná. 1998;56:31-8.
33. Weiss LM, Chang KL. Practical applications of immunohistochemistry. Short course handout. United States and Canadian Academy of Pathology Annual Meeting. 1999.
34. Raab SS. The cost-effectiveness of immunohistochemistry. Arch Pathol Lab Med. 2000;124:1185-91.
35. Taylor CR. The total test approach to standardization of immunohistochemistry. Arch Pathol Lab Med. 2000;124:945-51.
36. Werner M, Chott A, Fabiano A, et al. Effect of formalin tissue fixation and processing on immunohistochemistry. Am J Surg Pathol. 2000;24:1016-9.
37. Hsi ED. A practical approach for evaluating new antibodies in the clinical immunohistochemistry laboratory. Arch Pathol Lab Med. 2001;125:289-94.
38. Jaffer S, Bleiweiss IJ. Beyond hematoxylin and eosin-the role of immunohistochemistry in surgical pathology. Cancer Invest. 2004;22:445-65.
39. Yaziji H, Barry T. Diagnostic Immunohistochemistry: what can go wrong? Adv Anat Pathol. 2006;13:238-46.
40. Lewis SM. Quality assurance programmes in the United Kingdom. Ann Ist Super Sanita. 1995;31:53-9.
41. External evaluation of technical quality of immunohistochemistry. Results of a preliminary multicenter study. Immunohistochemistry Commission of the French Association of Quality Assurance in Pathology and Cytology (AFAQAP-IHC). Ann Pathol. 1997;17:129-33.
42. Frisman DM. "Immunoquerry." Retrieved 11 de janeiro de 2007.
43. Shi SR, Liu C, Taylor CR. Standardization of Immunohistochemistry for Formalin-fixed, Paraffin-embedded Tissue Sections Based on the Antigen Retrieval Technique: From Experiments to Hypothesis. J Histochem Cytochem. 2006;39:741-8.
44. Jacobs TW, Prioleau JE, Stillman IE, et al. Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer Inst. 1996;88:1054-9.
45. Manne U, Myers RB, Srivastava S, et al. Re: loss of tumor markerimmunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer Inst. 1997;89:585-6.
46. Wick MR. Algorithmic immunohistologic analysis of undifferentiated neoplasms. United States an Canadian Academy of Pathology Annual Meeting. 1995.
47. Wasielewski R, Komminoth P, Werner M. Influence of fixation, antibody clones, and signal amplification on steroid receptor analysis. Breast J. 1998;44:33-40.
48. Alves VA, Wakamatsu A, Kanamura CT, et al. The importance of fixation in immunohistochemistry: distribution of vimentin and cytokeratins in samples fixed in alcohol and formol. Rev Hosp Clin Fac Med Sao Paulo. 1992;47:19-24.
49. Balaton AL, Coindre JM, Collin F, et al. Recommendations for the immunohistochemical evaluation of hormone receptors on paraffin sections of breast cancer. Study Group on Hormone Receptors using Immunohistochemistry FNCLCC/AFAQAP. National Federation of Centres to Combat Cancer/French Association for Quality Assurance in Pathology. Ann Pathol. 1996;16:144-8.
50. Shi SR, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem. 1991;39:741-8.
51. Cattoretti G, Becker MH, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol. 1992;168:357-63.
52. Leong AS. Applied immunohistochemistry for the surgical pathologist. London: Edward Arnold Publishers. 1993.
53. Giorno R. A comparison of two immunoperoxidase staining methods based on the avidin-biotin interaction. Diagn Immunol. 1984;2:161-6.
54. Shi ZR, Itzkowitz SH, Kim YS. A comparison of three immunoperoxidase techniques for antigen detection in colorectal carcinoma tissues. J Histochem Cytochem. 1988;36:317-22.
55. Elias JM, Gaborc D. A comparison of the peroxidase-anti-peroxidase (PAP), avidin-biotin complex (ABC) and labeled avidin-biotin (LAB) methods for detection of glucagon in paraffin embedded human pancreas. Am J Clin Pathol. 1989;92:62.
56. Elias JM, Gown AM, Nakamura RM, et al. Quality control in immunohistochemistry. Report of a workshop sponsored by the Biological Stain Commission. Am J Clin Pathol. 1989;92:836-43.
57. Pastore JN, Clampett C, Miller JM, et al. A rapid immunoenzyme immunolabeling technique using EPOS reagens. J Histotech. 1995;18:35-40.
58. Bobrow MN, Harris TD, Shaughnessy KJ, et al. Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays. J Immunol Methods. 1989;125:279-85.
59. Bobrow MN, Litt GJ, Shaughnessy KJ, et al. The use of catalyzed reporter deposition as a means of signal amplification in a variety of formats. J Immunol Methods. 1992;150:145-9.
60. Jensen HE, Salonen J, Ekfors TO. The use of immunohistochemistry to improve sensitivity and specificity in the diagnosis of systemic mycoses in patients with haematological malignancies. J Pathol. 1997;181:100-5.
61. Jensen ML, Nielsen O, Johansen P, et al. Immunohistochemistry in tumor diagnosis. External quality assessment of 13 Departments of Pathology in Western Denmark. Appl Immunohistochem. 1997;5:35-44.
62. Prescott RJ, Wells S, Bisset DL, et al. Audit of tumour histopathology reviewed by a regional oncology centre. J Clin Pathol. 1995;48:245-9.
63. Lipman NS, Jackson LR, Trudel LJ, et al. Monoclonal versus polyclonal antibodies: distinguishing characteristics, applications, and information resources. Ilar J. 2005;46:258-68.
64. Elias JM. Immunohistopathology: a practical approach to diagnosis. Chicago: ASCP Press. 1990.
65. Taylor CR. An exaltation of experts: concerted efforts in the standardization of immunohistochemistry. Hum Pathol. 1994;25:2-11.
66. Seidal T, Balaton AJ, Battifora H. Interpretation and quantification of immunostains. Am J Surg Pathol. 2001;25:1204-7.
67. Collins RD. Is clonality equivalent to malignancy: specifically, is immunoglobulin gene rearrangement diagnostic of malignant lymphoma? Hum Pathol. 1997;28:757-9.
68. Radotra BD, Joshi K, Kak VK, et al. Choroid plexus tumours-an immunohistochemical analysis with review of literature. Indian J Pathol Microbiol. 1994;37:9-19.
69. Wrba F, Gullick WJ, Fertl H, et al. Immunohistochemical detection of the c-erbB-2 proto-oncogene product in normal, benign and malignant cartilage tissues. Histopathology. 1989;15:71-6.
70. Hall PA, Hughes CM, Staddon SL, et al. The c-erbB-2 proto-oncogene in human pancreatic cancer. J Pathol. 1990;161:195-200.
71. Zhau HE, Zhang X, von Eschenbach AC, et al. Amplification and expression of the c-erb B-2/neu proto-oncogene in human bladder cancer. Mol Carcinog. 1990;3:254-7.
72. Field JK, Spandidos DA, Yiagnisis M, et al. C-erbB-2 expression in squamous cell carcinoma of the head and neck. Anticancer Res. 1992;12:613-9.
73. Hicks DG, Tubbs RR. Assessment of the HER2 status in breast cancer by fluorescence in situ hybridization: a technical review with interpretive guidelines. Hum Pathol. 2005;36:250-61.
74. Stabenow E, Tavares MR, Ab'Saber AM, et al. Angiogenesis as an indicator of metastatic potential in papillary thyroid carcinoma. CLINICS. 2005;60:233-40.
75. Alves VAF, Leandro LO, Vassallo J, et al. Controle de qualidade interlaboratorial em imuno-histoquímica: citoceratinas e receptor de estrógeno como modelos. J Bras Patol Med Lab. 2004;40:175-83.
76. Polak JM, Pearse AG, Joffe S, et al. Quantification of secretion release by acid, using immunocytochemistry and radioimmunoassay. Experientia. 1975; 31:462-4.
77. Polak JM, Pearse AG, Van Mourik M, et al. Circadian rhythms of the endocrine pancreas. A quantitative biochemical and immumocytochemical study. Acta Hepatogastroenterol (Stuttg). 1975;22:118-22.
78. Fritz P, Hones J, Lutz D, et al. Quantitative immunohistochemistry: standardization and possible application in research and surgical pathology. Acta Histochem Suppl. 1989;37:213-9.
79. True LD. Quantitative immunohistochemistry: a new tool for surgical pathology? Am J Clin Pathol. 1988;90:324-5.
80. Becker RL Jr. Standardization and quality control of quantitative microscopy in pathology. J Cell Biochem. 1993;(Supp l)17G:199-204.
81. Taylor CR, Levenson RM. Quantification of immunohistochemistry-issues concerning methods, utility and semiquantitative assessment II. Histopathology. 2006;49:411-24.
82. Brey EM, Lalani Z, Johnston C, et al. Automated selection of DAB-labeled tissue for immunohistochemical quantification. J Histochem Cytochem. 2003;51:575-84.
83. Venter DJ, Tuzi NL, Kumar S, et al. Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification. Lancet. 1987;2:69-72.
84. Podhajsky RJ, Bidanset DJ, Caterson B, et al. A quantitative immunohistochemical study of the cellular response to crush injury in optic nerve. Exp Neurol. 1997;143:153-61.
85. Dias P, Chen B, Dilday B, et al. Strong immunostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclass. Am J Pathol. 2000;156:399-408.
86. Rieux C, Carney R, Lupi D, et al. Analysis of immunohistochemical label of Fos protein in the suprachiasmatic nucleus: comparison of different methods of quantification. J Biol Rhythms. 2002;17:121-36.
87. de Matos LL, Machado LN, Sugiyama MM, et al. Tecnologia aplicada na detecção de marcadores tumorais. Arq Med ABC. 2005;30:19-25.
88. Aasmundstad TA, Haugen OA, Johannesen E, et al. Oestrogen receptor analysis: correlation between enzyme immunoassay and immunohistochemical methods. J Clin Pathol. 1992;45:125-9.
89. Lehr HA, Mankoff DA, Corwin D, et al. Application of photoshop-based image analysis to quantification of hormone receptor expression in breast cancer. J Histochem Cytochem. 1997;45:1559-65.
90. Bhatnagar J, Tewari HB, Bhatnagar M, et al. Comparison of carcinoembryonic antigen in tissue and serum with grade and stage of colon cancer. Anticancer Res. 1999;19:2181-7.
91. Simone NL, Remaley AT, Charboneau L, et al. Sensitive immunoassay of tissue cell proteins procured by laser capture microdissection. Am J Pathol. 2000;156:445-52.
92. Baselga J, Perez EA, Pienkowski T, et al. Adjuvant trastuzumab: a milestone in the treatment of HER-2-positive early breast cancer. Oncologist. 2006;11(Suppl 1):4-12.
93. Heyderman E, Warren PJ, Haines AM. Immunocytochemistry todayproblems and practice. Histopathology. 1989;15:653-8.
94. Biesterfeld S, Veuskens U, Schmitz FJ, et al. Interobserver reproducibility of immunocytochemical estrogenand progesterone receptor status assessment in breast cancer. Anticancer Res. 1996;16:2497-500.
95. Press MF, Pike MC, Chazin VR, et al. Her-2/neu expression in nodenegative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease. Cancer Res. 1993;53:4960-70.
96. Walker RA. Quantification of immunohistochemistry-issues concerning methods, utility and semiquantitative assessment I. Histopathology. 2006; 49:406-10, 97.
97. Schuh D, Steidl R, Voss K. The differential diagnosis of follicular adenomas and carcinomas in fine needle biopsies of the thyroid gland by means of automatic image analysis. Zentralbl Allg Pathol. 1980;124:557-60.
98. Bacus S, Flowers JL, Press MF, et al. The evaluation of estrogen receptor in primary breast carcinoma by computer-assisted image analysis. Am J Clin Pathol. 1988;90:233-9.
99. Zhu QY. Analysis of blood vessel invasion by cells of thyroid follicular carcinoma using image processing combined with immunohistochemistry. Zhonghua Yi Xue Za Zhi. 1989;69:573-5, 40.
100. Holschbach A, Kriete A, Schaffer R. Differential diagnosis of papillary carcinomas of the thyroid, using image analysis and three dimensional reconstruction from serial sections. Verh Dtsch Ges Pathol. 1990;74:270-4.
101. Jensen MH, Davis RK, Derrick L. Thyroid cancer: a computer-assisted review of 5287 cases. Otolaryngol Head Neck Surg. 1990;102:51-65.
102. McClelland RA, Finlay P, Walker KJ, et al. Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer. Cancer Res. 1990;50:3545-50.
103. McClelland RA, Wilson D, Leake R, et al. A multicentre study into the reliability of steroid receptor immunocytochemical assay quantification. British Quality Control Group. Eur J Cancer. 1991;27:711-5.
104. Goto M, Nagatomo Y, Hasui K, et al. Chromaticity analysis of immunostained tumor specimens. Pathol Res Pract. 1992;188:433-7.
105. Salmon I, Kiss R, Franc B, et al. Comparison of morphonuclear features in normal, benign and neoplastic thyroid tissue by digital cell image analysis. Anal Quant Cytol Histol. 1992;14:47-54.
106. Borghi H, Calle A, Sesboue R, et al. Light microscopical detection of inter-alpha-trypsin inhibitor and its different mRNAs in cultured hepatoma Hep G2 cells using immunocytochemical and in situ hybridization techniques. Histochem J. 1994;26:252-61.
107. Huang X, Chen S, Tietz EI. Immunocytochemical detection of regional protein changes in rat brain sections using computer-assisted image analysis. J Histochem Cytochem. 1996;44:981-7.
108. Montironi R, Diamanti L, Thompson D, et al. Analysis of the capillary architecture in the precursors of prostate cancer: recent findings and new concepts. Eur Urol. 1996;30:191-200.
109. Ruifrok AC. Quantification of immunohistochemical staining by color translation and automated thresholding. Anal Quant Cytol Histol. 1997;19:107-13.
110. Smejkal GB, Shainoff JR. Enhanced digital imaging of diaminobenzidenestained immunoblots. Biotechniques. 1997;22:462.
111. Tseleni S, Kavantzas N, Yova D, et al. Findings of computerised nuclear morphometry of papillary thyroid carcinoma in correlation with known prognostic factors. J Exp Clin Cancer Res. 1997;16:401-6.
112. Gordower L, Decaestecker C, Kacem Y, et al. Galectin-3 and galectin3-binding site expression in human adult astrocytic tumours and related angiogenesis. Neuropathol Appl Neurobiol. 1999;25:319-30.
113. Kohlberger PD, Breitenecker F, Kaider A, et al. Modified true-color computer-assisted image analysis versus subjective scoring of estrogen receptor expression in breast cancer: a comparison. Anticancer Res. 1999;19:2189-93.
114. Ma W, Lozanoff S. A full color system for quantitative assessment of histochemical and immunohistochemical staining patterns. Biotech Histochem. 1999;74:1-9.
115. Vilaplana J, Lavialle M. A method to quantify glial fibrillary acidic protein immunoreactivity on the suprachiasmatic nucleus. J Neurosci Methods. 1999;88:181-7.
116. Matkowskyj KA, Schonfeld D, Benya RV. Quantitative immunohistochemistry by measuring cumulative signal strength using commercially available software photoshop and matlab. J Histochem Cytochem. 2000;48:303-12.
117. Lehr HA, Jacobs TW, Yaziji H, et al. Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis. Am J Clin Pathol. 2001;115:814-22.
118. Ruifrok AC, Johnston DA. Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol. 2001;23:291-9.
119. Underwood RA, Gibran NS, Muffley LA, et al. Color subtractive-computerassisted image analysis for quantification of cutaneous nerves in a diabetic mouse model. J Histochem Cytochem. 2001;49:1285-91.
120. Hardie DC, Gregory TR, Hebert PD. From pixels to picograms: a beginners' guide to genome quantification by Feulgen image analysis densitometry. J Histochem Cytochem. 2002;50:735-49.
121. King TW, Brey EM, Youssef AA, et al. Quantification of vascular density using a semiautomated technique for immunostained specimens. Anal Quant Cytol Histol. 2002;24:39-48.
122. de Matos LL, Stabenow E, Tavares MR, et al. Immunohistochemistry quantification by a digital computer-assisted method compared to semiquantitative analysis. Clinics. 2006;61:417-24.
123. Cross SS. Observer accuracy in estimating proportions in images: implications for the semiquantitative assessment of staining reactions and a proposal for a new system. J Clin Pathol. 2001;54:385-90.
124. Mayer G, Bendayan M. Amplification methods for the immunolocalization of rare molecules in cells and tissues. Prog Histochem Cytochem. 2001;36:3-85.
125. Brigati DJ, Budgeon HT, Under ER. Immunocytochemistry is automated: development of a robotic workstation based upon the capillary action principle. J Histotechnol. 1988;11:165-83.
126. Coindre JM. Immunohistochemistry in the diagnosis of soft tissue tumours. Histopathology. 2003;43:1-16.
127. Erler BS, Chein K, Marchevsky AM. An image analysis workstation for the pathology laboratory. Mod Pathol. 1993;6:612-8.